Cargando…

Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges

Obesity has reached an epidemic proportion in the last thirty years, and it is recognized as a major health issue in modern society now with the possibility of serious social and economic consequences. By the year 2030, nearly 60% of the global population may be obese or overweight, which emphasizes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashour, Mohamed M., Mabrouk, Mostafa, Aboelnasr, Mohamed A., Beherei, Hanan H., Tohamy, Khairy M., Das, Diganta B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674714/
https://www.ncbi.nlm.nih.gov/pubmed/38004612
http://dx.doi.org/10.3390/pharmaceutics15112635
_version_ 1785149742428192768
author Ashour, Mohamed M.
Mabrouk, Mostafa
Aboelnasr, Mohamed A.
Beherei, Hanan H.
Tohamy, Khairy M.
Das, Diganta B.
author_facet Ashour, Mohamed M.
Mabrouk, Mostafa
Aboelnasr, Mohamed A.
Beherei, Hanan H.
Tohamy, Khairy M.
Das, Diganta B.
author_sort Ashour, Mohamed M.
collection PubMed
description Obesity has reached an epidemic proportion in the last thirty years, and it is recognized as a major health issue in modern society now with the possibility of serious social and economic consequences. By the year 2030, nearly 60% of the global population may be obese or overweight, which emphasizes a need for novel obesity treatments. Various traditional approaches, such as pharmacotherapy and bariatric surgery, have been utilized in clinical settings to treat obesity. However, these methods frequently show the possibility of side effects while remaining ineffective. There is, therefore, an urgent need for alternative obesity treatments with improved efficacy and specificity. Polymeric materials and chemical strategies are employed in emerging drug delivery systems (DDSs) to enhance therapy effectiveness and specificity by stabilizing and controlling the release of active molecules such as natural ingredients. Designing DDSs is currently a top priority research objective with an eye towards creating obesity treatment approaches. In reality, the most recent trends in the literature demonstrate that there are not enough in-depth reviews that emphasize the current knowledge based on the creation and design of DDSs for obesity treatment. It is also observed in the existing literature that a complex interplay of different physical and chemical parameters must be considered carefully to determine the effectiveness of the DDSs, including microneedles, for obesity treatment. Additionally, it is observed that these properties depend on how the DDS is synthesized. Although many studies are at the animal-study stage, the use of more advanced DDS techniques would significantly enhance the development of safe and efficient treatment approaches for obese people in the future. Considering these, this review provides an overview of the current anti-obesity treatment approaches as well as the conventional anti-obesity therapeutics. The article aims to conduct an in-depth discussion on the current trends in obesity treatment approaches. Filling in this knowledge gap will lead to a greater understanding of the safest ways to manage obesity.
format Online
Article
Text
id pubmed-10674714
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106747142023-11-16 Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges Ashour, Mohamed M. Mabrouk, Mostafa Aboelnasr, Mohamed A. Beherei, Hanan H. Tohamy, Khairy M. Das, Diganta B. Pharmaceutics Review Obesity has reached an epidemic proportion in the last thirty years, and it is recognized as a major health issue in modern society now with the possibility of serious social and economic consequences. By the year 2030, nearly 60% of the global population may be obese or overweight, which emphasizes a need for novel obesity treatments. Various traditional approaches, such as pharmacotherapy and bariatric surgery, have been utilized in clinical settings to treat obesity. However, these methods frequently show the possibility of side effects while remaining ineffective. There is, therefore, an urgent need for alternative obesity treatments with improved efficacy and specificity. Polymeric materials and chemical strategies are employed in emerging drug delivery systems (DDSs) to enhance therapy effectiveness and specificity by stabilizing and controlling the release of active molecules such as natural ingredients. Designing DDSs is currently a top priority research objective with an eye towards creating obesity treatment approaches. In reality, the most recent trends in the literature demonstrate that there are not enough in-depth reviews that emphasize the current knowledge based on the creation and design of DDSs for obesity treatment. It is also observed in the existing literature that a complex interplay of different physical and chemical parameters must be considered carefully to determine the effectiveness of the DDSs, including microneedles, for obesity treatment. Additionally, it is observed that these properties depend on how the DDS is synthesized. Although many studies are at the animal-study stage, the use of more advanced DDS techniques would significantly enhance the development of safe and efficient treatment approaches for obese people in the future. Considering these, this review provides an overview of the current anti-obesity treatment approaches as well as the conventional anti-obesity therapeutics. The article aims to conduct an in-depth discussion on the current trends in obesity treatment approaches. Filling in this knowledge gap will lead to a greater understanding of the safest ways to manage obesity. MDPI 2023-11-16 /pmc/articles/PMC10674714/ /pubmed/38004612 http://dx.doi.org/10.3390/pharmaceutics15112635 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ashour, Mohamed M.
Mabrouk, Mostafa
Aboelnasr, Mohamed A.
Beherei, Hanan H.
Tohamy, Khairy M.
Das, Diganta B.
Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
title Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
title_full Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
title_fullStr Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
title_full_unstemmed Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
title_short Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
title_sort anti-obesity drug delivery systems: recent progress and challenges
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674714/
https://www.ncbi.nlm.nih.gov/pubmed/38004612
http://dx.doi.org/10.3390/pharmaceutics15112635
work_keys_str_mv AT ashourmohamedm antiobesitydrugdeliverysystemsrecentprogressandchallenges
AT mabroukmostafa antiobesitydrugdeliverysystemsrecentprogressandchallenges
AT aboelnasrmohameda antiobesitydrugdeliverysystemsrecentprogressandchallenges
AT behereihananh antiobesitydrugdeliverysystemsrecentprogressandchallenges
AT tohamykhairym antiobesitydrugdeliverysystemsrecentprogressandchallenges
AT dasdigantab antiobesitydrugdeliverysystemsrecentprogressandchallenges